The orodispersible formulation is particularly suitable for this indication because it dissolves instantly under the tongue with no unpleasant taste. Consequently, there is no need to take additional water to swallow a tablet, thereby helping the patient avoid fluids immediately before bedtime. In addition, the nature of the formulation means that the patient has no time to spit out the medication.
DDAVP Melt is available in 60 and 120 microgram strengths and is indicated for the treatment of cranial diabetes insipidus and for post-hypophysectomy polyuria/polydipsia.
DesmoMelt 120 micrograms is presented in packs of 30 orodispersible lyophilisates at a cost of £30.34.
DDAVP 60 micrograms and 120 micrograms are each presented in packs of 100 at a cost of £50.53 and £101.07, respectively.
Further information: Ferring Pharmaceuticals Ltd, The Courtyard, Waterside Drive, Langley, Berks SL3 6EZ. Tel: (01753) 214800.